The metabolic symbiosis phenomenon describes how tumour cells switch between aerobic glycolysis and OXPHOS, depending on the tumour microenvironment (TME) and amplified oncogenes such as MYCN [44,45]. This evidence concerns the gene MYCN and neoplasm.